ID

24801

Descrizione

Study ID: 101468/228 Clinical Study ID: 101468/228 Study Title:A two year Phase IIIb randomised, multicenter, double-blind, SINEMET controlled, parallel group, flexible dose study, to assess the effectiveness of controlled release ropinirole add-on therapy to L-dopa at increasing the time to onset of dyskinesia in Parkinson's disease subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00363727 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Dyskinesias; Parkinson Disease; Parkinson's Disease Study part: Non-serious adverse events

Keywords

versioni (4)
  1. 12/08/17 12/08/17 -
  2. 12/08/17 12/08/17 -
  3. 18/08/17 18/08/17 -
  4. 08/09/17 08/09/17 -
Titolare del copyright

GlaxoSmithKline

Caricato su

18 agosto 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Non-serious adverse events GSK study Dyskinesia in Parkinson's disease NCT00363727

Inglese

Non-serious adverse events GSK study Dyskinesia in Parkinson's disease NCT00363727

1 moduli  
General information
Descrizione

General information

Protocol indentifier
Descrizione

Protocol indentifier

Tipo di dati

text

Subject Identifier
Descrizione

Subject Identifier

Tipo di dati

text

Alias
UMLS CUI [1]
C2348585
Visit date
Descrizione

Visit date

Tipo di dati

date

Visit Description
Descrizione

Visit Description

Tipo di dati

text

Non-serious adverse events
Descrizione

Non-serious adverse events

Did the subject experience any non-serious adverse events during the study?
Descrizione

If Yes, record details below. Note: If this is a Serious Adverse Event (SAE), do not complete this form, go to the SAE section and complete the SAE form.

Tipo di dati

boolean

Event
Descrizione

Diagnosis Only (if known). Otherwise Sign/Symptom

Tipo di dati

text

Start date
Descrizione

Start date

Tipo di dati

date

Outcome
Descrizione

Outcome

Tipo di dati

integer

End Date
Descrizione

End Date

Tipo di dati

date

Maximum Intensity
Descrizione

Maximum Intensity

Tipo di dati

text

Action Taken with Investigational Product(s) as a Result of the Non-Serious AE
Descrizione

Action Taken

Tipo di dati

text

Did the subject withdraw from study as a result of this AE?
Descrizione

withdrawal

Tipo di dati

boolean

Is there a reasonable possibility that the AE may have been caused by the investigational product?
Descrizione

AE caused by the investigational product

Tipo di dati

boolean

Ritorna all'inizio della pagina

Similar models

Non-serious adverse events GSK study Dyskinesia in Parkinson's disease NCT00363727

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
General information
Protocol indentifier
Item
Protocol indentifier
text
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit date
Item
Visit date
date
Visit Description
Item
Visit Description
text
Item Group
Non-serious adverse events
non-serious adverse events
Item
Did the subject experience any non-serious adverse events during the study?
boolean
Event
Item
Event
text
Start date
Item
Start date
date
Item
Outcome
integer
Outcome
Code List
Outcome
CL Item
Recovered/Resolved (1)
CL Item
Recovering/Resolving (2)
CL Item
Not recovered/Not resolved (3)
CL Item
Recovered/Resolved withsequelae (4)
End Date
Item
End Date
date
Item
Maximum Intensity
text
Maximum Intensity
Code List
Maximum Intensity
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
CL Item
Not applicable (X)
Item
Action Taken with Investigational Product(s) as a Result of the Non-Serious AE
text
Action Taken
Code List
Action Taken with Investigational Product(s) as a Result of the Non-Serious AE
CL Item
Investigational product(s) withdrawn (1)
CL Item
Dose reduced (2)
CL Item
Dose increased (3)
CL Item
Dose not changed (4)
CL Item
Dose interrupted (5)
CL Item
Not applicable (X)
withdrawal
Item
Did the subject withdraw from study as a result of this AE?
boolean
AE caused by the investigational product
Item
Is there a reasonable possibility that the AE may have been caused by the investigational product?
boolean
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial